Monogram Technologies and Zimmer Biomet Extend Antitrust Review Period for Merger, Expected to Complete in Late 2025
Monogram Technologies Inc. has provided an update on its pending merger with Zimmer Biomet Holdings, Inc. The company announced that Zimmer Biomet, in agreement with Monogram, voluntarily withdrew and subsequently resubmitted its pre-merger Notification and Report Form to allow the Federal Trade Commission additional time for review. This move is part of the ongoing cooperation with regulatory authorities to facilitate the merger process. The new 30-day waiting period began on September 4, 2025, and is expected to conclude on October 6, 2025. Monogram and Zimmer Biomet remain committed to completing the merger in the second half of 2025, contingent on receiving necessary regulatory approvals and fulfilling other standard conditions.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Monogram Technologies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-087631), on September 05, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.